Advanced Diabetes Supply
About Advanced Diabetes Supply
Company overview
Advanced Diabetes Supply (ADS), founded in 2002 and headquartered in Carlsbad, California, is a national distributor specializing in durable medical equipment (DME) focused exclusively on diabetes supplies. The company serves patients across the United States through home delivery, insurance-billing support, and a broad product catalogue of diabetes-management devices and consumables. Products / Services: 1. Continuous Glucose Monitoring (CGM) Systems & Supplies - Provides sensors, transmitters, receivers, and accessory supplies from leading CGM brands for home use. - Focus on ensuring timely delivery, insurance coordination, and adherence to therapy via CGMs. hmenews.com 2. Insulin Pumps & Pump Supplies - Offers insulin-pump devices (tubed and tubeless) and related supplies (infusion sets, cartridges, etc). - Support around pump initiation, supplies refills, and integration with CGM when applicable. 3. Diabetes Testing Supplies & Glucose Meters - Distribution of blood-glucose meters, test strips, lancets, control solutions, and other consumables used in daily diabetes monitoring. - Includes management of insurance paperwork and home-delivery service of consumables. 4. Home-Delivery & Logistics Services for Diabetes Patients - Subscription-style delivery of diabetes supplies, including prescriptions, consumables, and devices, directly to patients' homes. - Coordination with payers, prescribers, and patient support to ensure continuity of care and timely renewals. 5. Insurance / Agent Support & Value-Based Care Services - Provides specialised support for insurance agents and brokers (e.g., managed care, Medicare), assisting clients in obtaining appropriate supplies with correct benefit coverage. - Emphasis on value-based health outcomes: ADS reports improved adherence and lower hospitalization risk when patients receive CGMs and supplies through their model.
Keywords
Revenue
Profit
Valuation
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenues | $380 MM | $250 MM | $90 MM | $120 MM | $65 MM |
| Gross Profit | $190 MM | $125 MM | $45 MM | $60 MM | $32.50 MM |
| Net Income (Loss) | $43 MM | $25 MM | $9 MM | $12 MM | $6.50 MM |
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $850 MM | $720 MM | $680 MM | $650 MM | $600 MM |
| Total Liabilities | $450 MM | $400 MM | $380 MM | $350 MM | $320 MM |
| Total Equity | $400 MM | $320 MM | $300 MM | $300 MM | $280 MM |
Ratios
Employee Figures
Key Executives
| Name | Title | Socials | Phone | |
|---|---|---|---|---|
| John Doe | Employee | -- | ||
| Jane Doe | Employee | |||
| John Doe | Employee | |||
| John Doe | Employee |
401K
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
© 2026 PrivCo Holding Inc. All rights reserved.
No AI Training or Automated Data Extraction.
Use of this page or any content or data made available by PrivCo for scraping, crawling, indexing, caching, extracting, copying, reproducing, storing, or for training or developing any artificial intelligence or machine learning system is strictly prohibited without prior written consent. All access to and use of this page and PrivCo's services are subject to the PrivCo Terms of Use: https://www.privco.com/terms-of-use. No license or right is granted by implication or otherwise.